Interestingly, we showed that TRIM8 expression recovery in two different RCC cell lines renders these cells sensitive to chemotherapeutic treatments, strongly supporting the role of TRIM8 in strengthening the p53-mediated response. This evidence concerns the gene TRIM8 and renal cell carcinoma.